Related Experiment Video
Updated: Mar 6, 2026

A Versatile Murine Model of Subcortical White Matter Stroke for the Study of Axonal Degeneration and White Matter Neurobiology
Published on: March 17, 2016
Multiple Factors Involved in the Pathogenesis of White Matter Lesions
Jing Lin1, Dilong Wang1, Linfang Lan2
1Department of Neurology, Guangdong Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department, National Key Discipline, First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Abstract:
White matter lesions (WMLs), also known as leukoaraiosis (LA) or white matter hyperintensities (WMHs), are characterized mainly by hyperintensities on T2-weighted or fluid-attenuated inversion recovery (FLAIR) images. With the aging of the population and the development of imaging technology, the morbidity and diagnostic rates of WMLs are increasing annually. WMLs are not a benign process. They clinically manifest as cognitive decline and the subsequent development of dementia. Although WMLs are important, their pathogenesis is still unclear. This review elaborates on the advances in the understanding of the pathogenesis of WMLs, focusing on anatomy, cerebral blood flow autoregulation, venous collagenosis, blood brain barrier disruption, and genetic factors. In particular, the attribution of WMLs to chronic ischemia secondary to venous collagenosis and cerebral blood flow autoregulation disruption seems reasonable. With the development of gene technology, the effect of genetic factors on the pathogenesis of WMLs is gaining gradual attention.
Insights
White matter lesions (WMLs) are increasingly diagnosed in aging populations and linked to cognitive decline. Research suggests chronic ischemia from venous collagenosis and impaired cerebral blood flow autoregulation are key causes.
Area of Science:
- Neurology
- Radiology
- Pathogenesis of neurological disorders
Background:
- White matter lesions (WMLs), also termed leukoaraiosis (LA) or white matter hyperintensities (WMHs), present as hyperintensities on T2-weighted/FLAIR MRI.
- Increasing diagnostic rates and prevalence of WMLs correlate with population aging and advanced imaging technology.
- WMLs are clinically significant, manifesting as cognitive decline and potentially leading to dementia.
Purpose of the Study:
- To review and synthesize current understanding of WML pathogenesis.
- To highlight key factors including anatomy, cerebral blood flow, venous collagenosis, blood-brain barrier integrity, and genetics.
- To emphasize emerging theories on chronic ischemia and genetic contributions.
Main Methods:
- Literature review and synthesis of existing research on WML pathogenesis.
- Focus on anatomical, physiological, and genetic factors implicated in WML development.
- Analysis of evidence supporting various etiological hypotheses.
Main Results:
- Pathogenesis of WMLs remains incompletely understood.
- Chronic ischemia secondary to venous collagenosis and disrupted cerebral blood flow autoregulation are plausible contributing factors.
- Genetic factors are increasingly recognized for their role in WML development.
Conclusions:
- Understanding WML pathogenesis is crucial due to their association with cognitive decline.
- Venous collagenosis and impaired cerebral blood flow autoregulation offer a compelling framework for WML etiology.
- Further research into genetic influences is warranted to fully elucidate WML pathogenesis.
Related Concept Videos
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Neurogenesis and Regeneration of Nervous Tissue
Atherosclerosis I: Introduction

